The Cell-free System is a technology for protein expression in an in vitro environment, and one of the characteristics of this technology is that it does not rely on living cells. It utilizes the translation mechanism of biomolecules extracted from cells of different species, as well as the addition of an expression template plasmid to provide the reaction substrate.
CD BioGlyco has long specialized in research in the field of biology and has delved deeply into glycobiology and the construction of cell-free systems. Relying on a high level of biological expertise, CD BioGlyco provides clients with a high-quality sialylated lactose-based cell-free system construction service.
Fig.1 A process of constructing a cell-free system based on sialylated lactose. (CD BioGlyco)
Enzymes play an important role in the construction and application of cell-free glycoengineering. We improve the ability of cell-free systems to prepare glycan molecules and glycoproteins by performing high-throughput screening of different enzymes.
For example, endoglycosynthase can disrupt specific glycosidic bonds in glycan molecules and prepare glycoproteins by transferring pre-synthesized glycans from glycosyl donors to acceptor proteins as a whole. In this process, we use glycooxazolines as glycosyl donors for glycoconjugates to facilitate transglycosylation yields.
In addition, we construct different glycoforms by different enzyme-mediated glycan remodeling reactions. In vitro, glycosylation analyses are performed to probe different enzyme substrate specificities and activities. For example, glycosyltransferases screened in strains of Escherichia coli used for in vitro glycoengineering tend to have more stringent substrate specificity and require extended glycosylated sequence subsequences.
We center on the sialylation pathway of lactose to construct cell-free systems and expand their applications.
Cell lysis: We extract cell lysates from cells expressing sialylated lactose on the cell surface.
Biomass extraction: Depending on the client's research needs, we use purified translation elements (e.g., various types of glycosyltransferases) to obtain cell-free systems.
Ingredient addition: We transfer the sialylation glycosylation mechanism of lactose to Escherichia coli strains to enable Escherichia coli to specifically transfer glycan sites to receptor proteins, thereby controlling the expression of target glycoproteins in a cell-free system.
Protein purification: Protein purification in the cell-free system is simpler and softer than in the live cell system, and we use liquid chromatography-mass spectrometry to purify the glycoproteins obtained.
Technology: Cell-free synthetic biology
Journal: Frontiers in Chemistry
IF: 5.5
Published: 2020
Results: In this article, the researchers used cell-free synthetic glycobiology as a highly modular framework to research and design glycan biosynthesis and biomolecule glycosylation pathways in the cell-free domain. In the process, the researchers also designed and constructed glycosyltransferase reaction systems utilizing a cell-free approach for the predictable and controllable production of glycan molecules.
Fig.2 Cell-free biological systems for biosynthesis of glycomolecules. (Jaroentomeechai, et al., 2020)
Cell-free system | Cell-based system |
|
|
CD BioGlyco has won the credibility of clients with leading biological technology, innovative products, and attentive service. We always adhere to the concept of professionalism first and dedicate ourselves to providing our clients with high-quality products and services. Please feel free to
if you have any questions, and our staff will answer you promptly.Reference